Sweden's Crown Princess Victoria joined Denmark's Queen Mary and Norway's Crown Princess Mette-Marit in Berlin ...

Ocean Biomedical, Inc. is a Providence, Rhode Island-based biopharma company with an innovative business model that ...

The final patient completing our pivotal F351 Phase 3 trial marks an important milestone for Gyre and our development pipeline. We are grateful to the patients, researchers, trial investigators, and ...

Oren Livnat, an analyst from H.C. Wainwright, reiterated the Buy rating on Trevi Therapeutics (TRVI – Research Report). The associated ...

GSK is pumping £50 million (about $65 million) into a five-year collaboration with the University of Cambridge and Cambridge ...

The National Institutes of Health has awarded $2.9 million to Arkansas Children's Research Institute to examine how a critical therapy for patients with cystic fibrosis might become even more ...

Structure Therapeutics has the potential to have a best-in-class GLP-1 agonist drug for treatment of patients with obesity. Learn more on GPCR stock here.

Exocrine pancreatic insufficiency (EPI) occurs in chronic pancreatitis, cystic fibrosis, autoimmune disorders such as Crohn’s disease and systemic lupus erythematosus and patients that have had parts ...

Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, ...

Washington Research Foundation (WRF) has awarded $6 million in grant funding through a new program designed to support late-stage preclinical development and first-in-human clinical trials of novel ...

Contineum Therapeutics (CTNM) stock gains as Baird launches coverage with an Outperform rating, highlighting the potential of ...

The Pulmonary Fibrosis Foundation (PFF), the nation's leading pulmonary fibrosis (PF) research, education and advocacy ...